Mark Yarborough, Nanette C. Joyce, et al. (2018) The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials, PLOS Biology 16(6), available at http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2006343
Paul Knoepfler, Too Much Carrot and Not Enough Stick in New Stem Cell Oversight Trends, Cell Stem Cell, Vol. 21, Issue 1, p. 18-20, available at https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(18)30286-8.
Leigh Turner & Paul Knoepfler, Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry, Cell Stem Cell, Vol. 19, Issue 2, p. 154-157, available at https://www.cell.com/cell-stem-cell/abstract/S1934-5909(16)30157-6
- Meaghan O’Keefe, Sarah Perrault, Jodi Halpern, Lisa Ikemoto, Mark Yarborough, “Editing” genes: A Case Study About How Language Matters in Bioethics, Amer. J. Bioethics, Vol. 15, 2015, Issue 12, available at https://www.tandfonline.com/doi/full/10.1080/15265161.2015.1103804
- Francoise Baylis & Lisa Ikemoto, The Council of Europe and the prohibition on human germline genome editing, EMBO Reports, Vol. 18, Issue 12, 15 Nov. 2017, available at https://onlinelibrary.wiley.com/doi/full/10.15252/embr.201745343
- Tina Rulli, The Mitochondrial Replacement ‘Therapy’ Myth, Bioethics, Vol. 21, Issue 5, 30 Dec. 2016, available at https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12332